Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer

Actas Urológicas Españolas (English Edition) - Tập 40 - Trang 434-439 - 2016
G. Gugliemetti1, R. Sukhu2, M.A. Conca Baenas1, J. Meeks1, D.D. Sjoberg2, J.A. Eastham1,3, P.T. Scardino1,3, K. Touijer1,3
1Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, Nueva York, NY, United States
2Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, Nueva York, NY, United States
3Department of Urology, Weill Medical College of Cornell University, Nueva York, NY, United States

Tài liệu tham khảo

Siegel, 2013, Cancer statistics, 2013, CA Cancer J Clin, 63, 11, 10.3322/caac.21166 Cooperberg, 2010, Time trends and local variation in primary treatment of localized prostate cancer, J Clin Oncol, 28, 1117, 10.1200/JCO.2009.26.0133 Shipley, 1999, Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis, JAMA, 281, 1598, 10.1001/jama.281.17.1598 Chade, 2011, Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration, Eur Urol, 60, 205, 10.1016/j.eururo.2011.03.011 Heidenreich, 2010, Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy, Eur Urol, 57, 437, 10.1016/j.eururo.2009.02.041 Chade, 2012, Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature, Eur Urol, 61, 961, 10.1016/j.eururo.2012.01.022 Sanderson, 2006, Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis, J Urol, 176, 2025, 10.1016/j.juro.2006.07.075 Touijer, 2007, Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%, J Urol, 178, 120, 10.1016/j.juro.2007.03.018 Eggener, 2011, Predicting 15-year prostate cancer specific mortality after radical prostatectomy, J Urol, 185, 869, 10.1016/j.juro.2010.10.057 Briganti, 2009, Eur Urol, 55 Touijer, 2013, Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy, Eur Urol Golimbu, 1987, Radical prostatectomy for stage D1 prostate cancer. Prognostic variables and results of treatment, Urology, 30, 427, 10.1016/0090-4295(87)90373-6 Daneshmand, 2004, Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results, J Urol, 172, 2252, 10.1097/01.ju.0000143448.04161.cc Schumacher, 2008, Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy, Eur Urol, 54, 344, 10.1016/j.eururo.2008.05.023 Von Bodman, 2010, Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy, J Urol, 184, 143, 10.1016/j.juro.2010.03.039